Domini Impact Investments’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-4,024
Closed -$288K 18
2017
Q4
$288K Sell
4,024
-657
-14% -$49.9K 5.9% 7
2017
Q3
$379K Hold
4,681
8.62% 5
2017
Q2
$331K Hold
4,681
8.4% 5
2017
Q1
$318K Sell
4,681
-225
-5% -$15.8K 10.17% 5
2016
Q4
$351K Hold
4,906
12.21% 2
2016
Q3
$388K Sell
4,906
-65
-1% -$5.28K 17.99% 1
2016
Q2
$415K Sell
4,971
-1,274
-20% -$113K 17.78% 1
2016
Q1
$574K Sell
6,245
-734
-11% -$66.2K 14.25% 1
2015
Q4
$706K Sell
6,979
-1,819
-21% -$189K 13.75% 1
2015
Q3
$864K Buy
8,798
+1,081
+14% +$120K 14.12% 1
2015
Q2
$904K Buy
7,717
+704
+10% +$76.9K 13.95% 1
2015
Q1
$688K Buy
7,013
+508
+8% +$51.6K 12.01% 2
2014
Q4
$613K Buy
6,505
+1,459
+29% +$151K 12.01% 3
2014
Q3
$537K Buy
5,046
+1,491
+42% +$146K 14.12% 2
2014
Q2
$295K Buy
+3,555
New +$277K 12.52% 4

Other funds holding GILD

Domini Impact Investments's GILD Position: Q1 2018 in Review

Domini Impact Investments sold out of Gilead Sciences (GILD) in Q1 2018, closing a stake of 4,024 shares — an estimated $288K sold.

Domini Impact Investments first reported a position in GILD in Q2 2014 and held it in 15 quarters. The position peaked at $904K in Q2 2015. 1,564 funds tracked by Wall St. Rank hold GILD as of Q1 2018.

  • Domini Impact Investments reported no remaining Gilead Sciences position as of Q1 2018 after selling out during the quarter.
  • Domini Impact Investments sold 4,024 Gilead Sciences shares in Q1 2018, an estimated $288K.
  • Domini Impact Investments first reported a position in Gilead Sciences in Q2 2014 and held it in 15 quarters.
  • Domini Impact Investments's Gilead Sciences position peaked at $904K in Q2 2015.
  • 1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.

Based on Domini Impact Investments's 13F filing for Q1 2018, filed 11 May 2018.